Cellebrite (CLBT) Director Adam Clammer Receives RSU Award

What Happened
Adam Clammer, a director of Cellebrite DI Ltd. (CLBT), received an award of 15,190 restricted share units (RSUs) on September 17, 2026. The reported acquisition price is $0.00 (no immediate cash paid) and the RSUs will vest on September 17, 2027; each RSU represents a contingent right to one ordinary share upon settlement (Footnote F1). The filing reports $0 in consideration for this grant.

Key Details

• Transaction date: 2026-09-17; reported on Form 4 filed 2026-09-28 (11 days after the transaction). Section 16 filings are generally due within two business days, so this report was filed after the usual deadline.
• Transaction type/code: A — Award/Grant of RSUs. Price reported: $0.00.
• Shares received: 15,190 RSUs; total value reported on Form 4: $0 (grant), with settlement contingent on vesting.
• Shares owned after transaction: not specified in the provided filing details.
• Notable footnotes:
  • F1: RSUs vest on 2027-09-17; each RSU converts to one ordinary share on settlement.
  • F2: Filing notes inclusion of 1,500,000 ordinary shares subject to performance-based restrictions.
  • F3–F4: Mr. Clammer may be deemed to share beneficial ownership of securities held by TWC Tech Holdings II, LLC (as a managing member) but disclaims beneficial ownership except to the extent of his pecuniary interest; inclusion in this report is not an admission of beneficial ownership.

Context
RSU awards are a form of compensation and are not an open-market purchase or sale; they represent a contingent right to receive shares if vesting conditions are met. This grant does not indicate an immediate cash investment by the insider. The late filing may be noted by investors tracking insider reporting timeliness.